Skip to content

Medical-device intelligence

LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation

FDA product code LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LON
FDA device name
System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
Device class
2
Regulation number
866.1645
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

293 clearance records and 240 recall records in the covered releases, across 22 source company names and 1 product codes. Dated history runs from Aug 1, 1986 to Nov 4, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202610
April 202610
May 202600
June 202603
July 202601
August 202602
September 202610
October 202610

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

533 matching records
Device / recordCompany in FDA recordSourceSource date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFUROXIME (GN) 1-64 UG/MLK062207 · LONBecton, Dickinson & CO510(k)Sep 13, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - MOXIFLOXACIN (STREP) 0.0625 - 8UG/MLK062206 · LONBecton, Dickinson & CO510(k)Sep 8, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-PIPERACILLIN-TAZOBACTAM (GP) 1/4-128/4 UG/MLK061869 · LONBecton, Dickinson & CO510(k)Aug 18, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFAZOLIN (GN) 0.5-32 UG/MLK061867 · LONBecton, Dickinson & CO510(k)Aug 10, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-AMOXICILLIN-CLAVULANATE(GP) 0.25/0.12 -32/16 UG/MLK061673 · LONBecton, Dickinson & CO510(k)Jul 28, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-AMOXICILLIN-CLAVULANATE (GN) 0.5/0.25-32/16 UG/ML, AMPICILLIN-SULBACTAM (GN) 0.K061327 · LONBecton, Dickinson & CO510(k)Jul 3, 2006FDA decision date
VITEK 2 GRAM POSITIVE VRSA SCREENK061347 · LONbioMerieux, Inc.510(k)Jun 20, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AMPICILLIN (GN) 0.5-32 UG/MLK061355 · LONBecton, Dickinson & CO510(k)Jun 7, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM FOR USE WITH THE ANTIMICROBIAL AGENT GATIFLOXACIN 0.25-8 UG/ML - GRAM-NEGATIVEK060324 · LONBecton, Dickinson & CO510(k)May 25, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEPHALOTHIN - GN 1 - 64 UG/MLK060558 · LONBecton, Dickinson & CO510(k)May 11, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM -NITROFURANTOIN (GN) 8-512 UG/ML, TRIMETHOPRIM-SULFAMETHOXAZOLE (GN)K060447 · LONBecton, Dickinson & CO510(k)Apr 26, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOXITIN - 0.5-64 UG/MLK060257 · LONBecton, Dickinson & CO510(k)Apr 14, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - MOXIFLOXACIN-0.125-8 AND CIPROFLOXACIN-0.25 - 4 UG/MLK060217 · LONBecton, Dickinson & CO510(k)Apr 12, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFEPIME (GN) , CEFTRIAXONE (GN), CEFOTAXIME (GN), 0.5-64 UG/MLK060444 · LONBecton, Dickinson & CO510(k)Apr 12, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - VANCOMYCIN-GP DETECTION OF VRSA.K060493 · LONBecton, Dickinson & CO510(k)Mar 29, 2006FDA decision date
MICROSCAN SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH VANCOMYCIN (0.25-64 UG/ML)K060312 · LONDade Behring, Inc.510(k)Mar 23, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - ERYTHROMYCIN-0.0625-8 UG/ML, AND QUINUPRISTIN/DALFOPRISTIN-0.25-4 UG/MLK060218 · LONBecton, Dickinson & CO510(k)Mar 17, 2006FDA decision date
BD PHOENIX AUTOMATED MIRCROBIOLOGY SYSTEM TETRACYCLINE-GN 0.5-16 UG/ML AND GP 0.5-16 UG/MLK060214 · LONBecton, Dickinson & CO510(k)Mar 9, 2006FDA decision date
MICROSCAN SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH ERYTHROMYCIN (0.12-16 UG/ML)K053504 · LONDade Behring, Inc.510(k)Feb 24, 2006FDA decision date
MICROSCAN SYNERGIES PLUS GRAM POSITIVE MIC/COMBO PANELS - AMPICILLINK060088 · LONDade Behring, Inc.510(k)Feb 3, 2006FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOXITIN GP 1-32 G/MLK053241 · LONBecton, Dickinson & CO510(k)Dec 22, 2005FDA decision date
VITEK 2 GRAM POSITIVE CEFOXITIN SCREENK053097 · LONbioMerieux, Inc.510(k)Dec 14, 2005FDA decision date
VITEK 2 GRAM POSITIVE TELITHROMYCIN FOR STREPTOCOCCUS PNEUMONIAEK053186 · LONbioMerieux, Inc.510(k)Dec 1, 2005FDA decision date
VITEK GRAM POSITIVE SUSCEPTIBILITY DAPTOMYCINK052656 · LONbioMerieux, Inc.510(k)Nov 7, 2005FDA decision date
SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELSK052346 · LONDade Behring, Inc.510(k)Oct 26, 2005FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗